Burden of parkinsonism: A population‐based study
Identifieur interne : 000466 ( Istex/Corpus ); précédent : 000465; suivant : 000467Burden of parkinsonism: A population‐based study
Auteurs : Mark Guttman ; Pamela M. Slaughter ; Marc-Erick Theriault ; Donald P. Deboer ; C. David NaylorSource :
- Movement Disorders [ 0885-3185 ] ; 2003-03.
English descriptors
Abstract
Parkinson's disease (PD) is associated with a significant burden of illness and cost to society, which has been difficult to quantify. Our objective was to use linked administrative databases from the population of Ontario, Canada, to assess the prevalence of parkinsonism, physician‐ and drug‐related costs, and hospital utilization for parkinsonian patients compared with age/sex matched controls. An inception cohort of parkinsonian cases from 1993/1994 was age and sex matched (1:2) to controls and followed for 6 years. Patients were identified by the diagnostic code for PD, the use of specific PD drugs, or a combination. The parkinsonian case cohort (15,304) was matched to (30,608) controls that did not have parkinsonism. The age‐adjusted prevalence rates were 3.63 for men and for 3.24 women per 1,000 (increased by 5.4% for men and 9.8% for women). Physician costs were 1.4 times more, there were 1.44 times more hospital admissions, admissions were on average 1.19 times longer, and drug costs were 3.0 times more for parkinsonian cases. We conclude that the substantially higher physician and drug costs as well as hospitalization rates compared with controls clearly suggest that parkinsonism is associated with large direct costs to society. © 2002 Movement Disorder Society
Url:
DOI: 10.1002/mds.10333
Links to Exploration step
ISTEX:A7F92FF4B90F12EF9D399824291014990DEAD217Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Burden of parkinsonism: A population‐based study</title><author><name sortKey="Guttman, Mark" sort="Guttman, Mark" uniqKey="Guttman M" first="Mark" last="Guttman">Mark Guttman</name><affiliation><mods:affiliation>Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada</mods:affiliation></affiliation><affiliation><mods:affiliation>377 Church Street no. 407, Markham, Ontario, Canada L6B 1A1</mods:affiliation></affiliation></author><author><name sortKey="Slaughter, Pamela M" sort="Slaughter, Pamela M" uniqKey="Slaughter P" first="Pamela M." last="Slaughter">Pamela M. Slaughter</name><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Theriault, Marc Rick" sort="Theriault, Marc Rick" uniqKey="Theriault M" first="Marc-Erick" last="Theriault">Marc-Erick Theriault</name><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Deboer, Donald P" sort="Deboer, Donald P" uniqKey="Deboer D" first="Donald P." last="Deboer">Donald P. Deboer</name><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Naylor, C David" sort="Naylor, C David" uniqKey="Naylor C" first="C. David" last="Naylor">C. David Naylor</name><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</mods:affiliation></affiliation><affiliation><mods:affiliation>Dean's Office, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A7F92FF4B90F12EF9D399824291014990DEAD217</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1002/mds.10333</idno><idno type="url">https://api-v5.istex.fr/document/A7F92FF4B90F12EF9D399824291014990DEAD217/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000466</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000466</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Burden of parkinsonism: A population‐based study</title><author><name sortKey="Guttman, Mark" sort="Guttman, Mark" uniqKey="Guttman M" first="Mark" last="Guttman">Mark Guttman</name><affiliation><mods:affiliation>Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada</mods:affiliation></affiliation><affiliation><mods:affiliation>377 Church Street no. 407, Markham, Ontario, Canada L6B 1A1</mods:affiliation></affiliation></author><author><name sortKey="Slaughter, Pamela M" sort="Slaughter, Pamela M" uniqKey="Slaughter P" first="Pamela M." last="Slaughter">Pamela M. Slaughter</name><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Theriault, Marc Rick" sort="Theriault, Marc Rick" uniqKey="Theriault M" first="Marc-Erick" last="Theriault">Marc-Erick Theriault</name><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Deboer, Donald P" sort="Deboer, Donald P" uniqKey="Deboer D" first="Donald P." last="Deboer">Donald P. Deboer</name><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Naylor, C David" sort="Naylor, C David" uniqKey="Naylor C" first="C. David" last="Naylor">C. David Naylor</name><affiliation><mods:affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</mods:affiliation></affiliation><affiliation><mods:affiliation>Dean's Office, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><date type="published" when="2003-03">2003-03</date><biblScope unit="volume">18</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="313">313</biblScope><biblScope unit="page" to="319">319</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">A7F92FF4B90F12EF9D399824291014990DEAD217</idno><idno type="DOI">10.1002/mds.10333</idno><idno type="ArticleID">MDS10333</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>epidemiology</term><term>health services research</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is associated with a significant burden of illness and cost to society, which has been difficult to quantify. Our objective was to use linked administrative databases from the population of Ontario, Canada, to assess the prevalence of parkinsonism, physician‐ and drug‐related costs, and hospital utilization for parkinsonian patients compared with age/sex matched controls. An inception cohort of parkinsonian cases from 1993/1994 was age and sex matched (1:2) to controls and followed for 6 years. Patients were identified by the diagnostic code for PD, the use of specific PD drugs, or a combination. The parkinsonian case cohort (15,304) was matched to (30,608) controls that did not have parkinsonism. The age‐adjusted prevalence rates were 3.63 for men and for 3.24 women per 1,000 (increased by 5.4% for men and 9.8% for women). Physician costs were 1.4 times more, there were 1.44 times more hospital admissions, admissions were on average 1.19 times longer, and drug costs were 3.0 times more for parkinsonian cases. We conclude that the substantially higher physician and drug costs as well as hospitalization rates compared with controls clearly suggest that parkinsonism is associated with large direct costs to society. © 2002 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Mark Guttman MD, FRCPC</name><affiliations><json:string>Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada</json:string><json:string>377 Church Street no. 407, Markham, Ontario, Canada L6B 1A1</json:string></affiliations></json:item><json:item><name>Pamela M. Slaughter RN, MA, MSc</name><affiliations><json:string>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</json:string></affiliations></json:item><json:item><name>Marc‐Erick Theriault MSc</name><affiliations><json:string>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</json:string></affiliations></json:item><json:item><name>Donald P. DeBoer MMath</name><affiliations><json:string>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</json:string></affiliations></json:item><json:item><name>C. David Naylor MD, DPhil, FRCPC</name><affiliations><json:string>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</json:string><json:string>Dean's Office, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>epidemiology</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>health services research</value></json:item></subject><articleId><json:string>MDS10333</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>Parkinson's disease (PD) is associated with a significant burden of illness and cost to society, which has been difficult to quantify. Our objective was to use linked administrative databases from the population of Ontario, Canada, to assess the prevalence of parkinsonism, physician‐ and drug‐related costs, and hospital utilization for parkinsonian patients compared with age/sex matched controls. An inception cohort of parkinsonian cases from 1993/1994 was age and sex matched (1:2) to controls and followed for 6 years. Patients were identified by the diagnostic code for PD, the use of specific PD drugs, or a combination. The parkinsonian case cohort (15,304) was matched to (30,608) controls that did not have parkinsonism. The age‐adjusted prevalence rates were 3.63 for men and for 3.24 women per 1,000 (increased by 5.4% for men and 9.8% for women). Physician costs were 1.4 times more, there were 1.44 times more hospital admissions, admissions were on average 1.19 times longer, and drug costs were 3.0 times more for parkinsonian cases. We conclude that the substantially higher physician and drug costs as well as hospitalization rates compared with controls clearly suggest that parkinsonism is associated with large direct costs to society. © 2002 Movement Disorder Society</abstract><qualityIndicators><score>6.773</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1290</abstractCharCount><pdfWordCount>4397</pdfWordCount><pdfCharCount>29050</pdfCharCount><pdfPageCount>7</pdfPageCount><abstractWordCount>198</abstractWordCount></qualityIndicators><title>Burden of parkinsonism: A population‐based study</title><genre><json:string>article</json:string></genre><host><title>Movement Disorders</title><language><json:string>unknown</json:string></language><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi><issn><json:string>0885-3185</json:string></issn><eissn><json:string>1531-8257</json:string></eissn><publisherId><json:string>MDS</json:string></publisherId><volume>18</volume><issue>3</issue><pages><first>313</first><last>319</last><total>7</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Brief Report</value></json:item></subject></host><categories><wos><json:string>science</json:string><json:string>clinical neurology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>neurology & neurosurgery</json:string></scienceMetrix></categories><publicationDate>2003</publicationDate><copyrightDate>2003</copyrightDate><doi><json:string>10.1002/mds.10333</json:string></doi><id>A7F92FF4B90F12EF9D399824291014990DEAD217</id><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api-v5.istex.fr/document/A7F92FF4B90F12EF9D399824291014990DEAD217/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api-v5.istex.fr/document/A7F92FF4B90F12EF9D399824291014990DEAD217/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api-v5.istex.fr/document/A7F92FF4B90F12EF9D399824291014990DEAD217/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Burden of parkinsonism: A population‐based study</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><availability><p>Copyright © 2003 Movement Disorders Society</p></availability><date>2003</date></publicationStmt><notesStmt><note>Parkinson's Foundation of Canada</note><note>National Parkinson Foundation (Miami)</note><note>Center of Excellence Award</note><note>Institute for Clinical Evaluative Sciences</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Burden of parkinsonism: A population‐based study</title><author xml:id="author-1"><persName><forename type="first">Mark</forename><surname>Guttman</surname></persName><roleName type="degree">MD, FRCPC</roleName><affiliation>Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada</affiliation><affiliation>377 Church Street no. 407, Markham, Ontario, Canada L6B 1A1</affiliation></author><author xml:id="author-2"><persName><forename type="first">Pamela M.</forename><surname>Slaughter</surname></persName><roleName type="degree">RN, MA, MSc</roleName><affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</affiliation></author><author xml:id="author-3"><persName><forename type="first">Marc‐Erick</forename><surname>Theriault</surname></persName><roleName type="degree">MSc</roleName><affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</affiliation></author><author xml:id="author-4"><persName><forename type="first">Donald P.</forename><surname>DeBoer</surname></persName><roleName type="degree">MMath</roleName><affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</affiliation></author><author xml:id="author-5"><persName><forename type="first">C. David</forename><surname>Naylor</surname></persName><roleName type="degree">MD, DPhil, FRCPC</roleName><affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</affiliation><affiliation>Dean's Office, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><date type="published" when="2003-03"></date><biblScope unit="volume">18</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="313">313</biblScope><biblScope unit="page" to="319">319</biblScope></imprint></monogr><idno type="istex">A7F92FF4B90F12EF9D399824291014990DEAD217</idno><idno type="DOI">10.1002/mds.10333</idno><idno type="ArticleID">MDS10333</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2003</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Parkinson's disease (PD) is associated with a significant burden of illness and cost to society, which has been difficult to quantify. Our objective was to use linked administrative databases from the population of Ontario, Canada, to assess the prevalence of parkinsonism, physician‐ and drug‐related costs, and hospital utilization for parkinsonian patients compared with age/sex matched controls. An inception cohort of parkinsonian cases from 1993/1994 was age and sex matched (1:2) to controls and followed for 6 years. Patients were identified by the diagnostic code for PD, the use of specific PD drugs, or a combination. The parkinsonian case cohort (15,304) was matched to (30,608) controls that did not have parkinsonism. The age‐adjusted prevalence rates were 3.63 for men and for 3.24 women per 1,000 (increased by 5.4% for men and 9.8% for women). Physician costs were 1.4 times more, there were 1.44 times more hospital admissions, admissions were on average 1.19 times longer, and drug costs were 3.0 times more for parkinsonian cases. We conclude that the substantially higher physician and drug costs as well as hospitalization rates compared with controls clearly suggest that parkinsonism is associated with large direct costs to society. © 2002 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>keywords</head><item><term>Parkinson's disease</term></item><item><term>epidemiology</term></item><item><term>health services research</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article-category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2002-05-13">Received</change><change when="2002-08-13">Registration</change><change when="2003-03">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api-v5.istex.fr/document/A7F92FF4B90F12EF9D399824291014990DEAD217/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>New York</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="30"><doi origin="wiley" registered="yes">10.1002/mds.v18:3</doi><numberingGroup><numbering type="journalVolume" number="18">18</numbering><numbering type="journalIssue">3</numbering></numberingGroup><coverDate startDate="2003-03">March 2003</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="100" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.10333</doi><idGroup><id type="unit" value="MDS10333"></id></idGroup><countGroup><count type="pageTotal" number="7"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 2003 Movement Disorders Society</copyright><eventGroup><event type="manuscriptReceived" date="2002-05-13"></event><event type="manuscriptRevised" date="2002-07-17"></event><event type="manuscriptAccepted" date="2002-08-13"></event><event type="firstOnline" date="2002-11-07"></event><event type="publishedOnlineFinalForm" date="2003-02-28"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2002-11-07"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">313</numbering><numbering type="pageLast">319</numbering></numberingGroup><correspondenceTo>377 Church Street no. 407, Markham, Ontario, Canada L6B 1A1</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS10333.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="4"></count><count type="referenceTotal" number="26"></count><count type="wordTotal" number="5077"></count></countGroup><titleGroup><title type="main" xml:lang="en">Burden of parkinsonism: A population‐based study</title><title type="short" xml:lang="en">Burden of Parkinsonism</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Mark</givenNames><familyName>Guttman</familyName><degrees>MD, FRCPC</degrees></personName><contactDetails><email>mguttman@idirect.com</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Pamela M.</givenNames><familyName>Slaughter</familyName><degrees>RN, MA, MSc</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Marc‐Erick</givenNames><familyName>Theriault</familyName><degrees>MSc</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Donald P.</givenNames><familyName>DeBoer</familyName><degrees>MMath</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af2 #af3"><personName><givenNames>C. David</givenNames><familyName>Naylor</familyName><degrees>MD, DPhil, FRCPC</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="CA" type="organization"><unparsedAffiliation>Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="CA" type="organization"><unparsedAffiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="CA" type="organization"><unparsedAffiliation>Dean's Office, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson's disease</keyword><keyword xml:id="kwd2">epidemiology</keyword><keyword xml:id="kwd3">health services research</keyword></keywordGroup><fundingInfo><fundingAgency>Parkinson's Foundation of Canada</fundingAgency></fundingInfo><fundingInfo><fundingAgency>National Parkinson Foundation (Miami)</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Center of Excellence Award</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Institute for Clinical Evaluative Sciences</fundingAgency></fundingInfo><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Parkinson's disease (PD) is associated with a significant burden of illness and cost to society, which has been difficult to quantify. Our objective was to use linked administrative databases from the population of Ontario, Canada, to assess the prevalence of parkinsonism, physician‐ and drug‐related costs, and hospital utilization for parkinsonian patients compared with age/sex matched controls. An inception cohort of parkinsonian cases from 1993/1994 was age and sex matched (1:2) to controls and followed for 6 years. Patients were identified by the diagnostic code for PD, the use of specific PD drugs, or a combination. The parkinsonian case cohort (15,304) was matched to (30,608) controls that did not have parkinsonism. The age‐adjusted prevalence rates were 3.63 for men and for 3.24 women per 1,000 (increased by 5.4% for men and 9.8% for women). Physician costs were 1.4 times more, there were 1.44 times more hospital admissions, admissions were on average 1.19 times longer, and drug costs were 3.0 times more for parkinsonian cases. We conclude that the substantially higher physician and drug costs as well as hospitalization rates compared with controls clearly suggest that parkinsonism is associated with large direct costs to society. © 2002 Movement Disorder Society</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Burden of parkinsonism: A population‐based study</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Burden of Parkinsonism</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Burden of parkinsonism: A population‐based study</title></titleInfo><name type="personal"><namePart type="given">Mark</namePart><namePart type="family">Guttman</namePart><namePart type="termsOfAddress">MD, FRCPC</namePart><affiliation>Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada</affiliation><affiliation>377 Church Street no. 407, Markham, Ontario, Canada L6B 1A1</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Pamela M.</namePart><namePart type="family">Slaughter</namePart><namePart type="termsOfAddress">RN, MA, MSc</namePart><affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Marc‐Erick</namePart><namePart type="family">Theriault</namePart><namePart type="termsOfAddress">MSc</namePart><affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Donald P.</namePart><namePart type="family">DeBoer</namePart><namePart type="termsOfAddress">MMath</namePart><affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C. David</namePart><namePart type="family">Naylor</namePart><namePart type="termsOfAddress">MD, DPhil, FRCPC</namePart><affiliation>Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada</affiliation><affiliation>Dean's Office, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">New York</placeTerm></place><dateIssued encoding="w3cdtf">2003-03</dateIssued><dateCaptured encoding="w3cdtf">2002-05-13</dateCaptured><dateValid encoding="w3cdtf">2002-08-13</dateValid><copyrightDate encoding="w3cdtf">2003</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="tables">4</extent><extent unit="references">26</extent><extent unit="words">5077</extent></physicalDescription><abstract lang="en">Parkinson's disease (PD) is associated with a significant burden of illness and cost to society, which has been difficult to quantify. Our objective was to use linked administrative databases from the population of Ontario, Canada, to assess the prevalence of parkinsonism, physician‐ and drug‐related costs, and hospital utilization for parkinsonian patients compared with age/sex matched controls. An inception cohort of parkinsonian cases from 1993/1994 was age and sex matched (1:2) to controls and followed for 6 years. Patients were identified by the diagnostic code for PD, the use of specific PD drugs, or a combination. The parkinsonian case cohort (15,304) was matched to (30,608) controls that did not have parkinsonism. The age‐adjusted prevalence rates were 3.63 for men and for 3.24 women per 1,000 (increased by 5.4% for men and 9.8% for women). Physician costs were 1.4 times more, there were 1.44 times more hospital admissions, admissions were on average 1.19 times longer, and drug costs were 3.0 times more for parkinsonian cases. We conclude that the substantially higher physician and drug costs as well as hospitalization rates compared with controls clearly suggest that parkinsonism is associated with large direct costs to society. © 2002 Movement Disorder Society</abstract><note type="funding">Parkinson's Foundation of Canada</note><note type="funding">National Parkinson Foundation (Miami)</note><note type="funding">Center of Excellence Award</note><note type="funding">Institute for Clinical Evaluative Sciences</note><subject lang="en"><genre>keywords</genre><topic>Parkinson's disease</topic><topic>epidemiology</topic><topic>health services research</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="journal">journal</genre><subject><genre>article-category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><detail type="issue"><caption>no.</caption><number>3</number></detail><extent unit="pages"><start>313</start><end>319</end><total>7</total></extent></part></relatedItem><identifier type="istex">A7F92FF4B90F12EF9D399824291014990DEAD217</identifier><identifier type="DOI">10.1002/mds.10333</identifier><identifier type="ArticleID">MDS10333</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2003 Movement Disorders Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000466 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000466 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:A7F92FF4B90F12EF9D399824291014990DEAD217
|texte= Burden of parkinsonism: A population‐based study
}}
| This area was generated with Dilib version V0.6.29. |  |